Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
28.27
-0.57 (-1.99%)
At close: Oct 17, 2025, 4:00 PM EDT
28.29
+0.02 (0.09%)
After-hours: Oct 17, 2025, 4:10 PM EDT
Zai Lab Employees
Zai Lab had 1,869 employees as of December 31, 2024. The number of employees decreased by 306 or -14.07% compared to the previous year.
Employees
1,869
Change (1Y)
-306
Growth (1Y)
-14.07%
Revenue / Employee
$228,892
Profits / Employee
-$113,708
Market Cap
3.15B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,869 | -306 | -14.07% |
Dec 31, 2023 | 2,175 | 139 | 6.83% |
Dec 31, 2022 | 2,036 | 85 | 4.36% |
Dec 31, 2021 | 1,951 | 757 | 63.40% |
Dec 31, 2020 | 1,194 | 502 | 72.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZLAB News
- 3 days ago - Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 - Business Wire
- 4 days ago - Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - Business Wire
- 5 weeks ago - Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback - Benzinga
- 5 weeks ago - Zai Lab Limited (ZLAB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong - Business Wire
- 7 weeks ago - Zai Lab Announces Participation in Investor Conferences in September 2025 - Business Wire
- 2 months ago - Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer - Business Wire
- 2 months ago - Zai Lab Establishes Oncology Scientific Advisory Board - Business Wire